P146 Golimumab in Rheumatoid and Psoriatic Arthritis. The Relationship Between Minimum Serum Concentration, Anti-Golimumab Antibodies and Activity of Disease

doi 10.1136/annrheumdis-2018-ewrr2019.129
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ Publishing Group Ltd and European League Against Rheumatism

Related search

Relationship Between Anti-CCP Antibodies and Oxidant and Anti-Oxidant Activity in Patients With Rheumatoid Arthritis

International Journal of Medical Sciences
Medicine
2011English

The Effect of Golimumab on Arterial Stiffness in Patients With Rheumatoid Arthritis

Nauchno-Prakticheskaya Revmatologiya
RheumatologyAllergyImmunology
2018English

Efficacy and Safety of Intravenous Golimumab Through 1 Year in Patients With Active Psoriatic Arthritis

Arthritis Care and Research
Rheumatology
2019English

PMS75 Annual Golimumab Utilization and Costs for Psoriatic Arthritis Patients Enrolled in Managed Care Plans

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2012English

The Association of Anti-CCP Antibodies With Disease Activity in Rheumatoid Arthritis

Rheumatology International
RheumatologyAllergyImmunology
2008English

Serum Boron Concentration in Rheumatoid Arthritis: Correlation With Disease Activity, Functional Class, and Rheumatoid Factor

Journal of Experimental and Integrative Medicine
Alternative MedicineComplementary
2013English

The Relationship Between Vitamin D Level and Disease Activity in Patients With Rheumatoid Arthritis

The Annals of Clinical and Analytical Medicine
2020English

Relationship Between Vitamin D and Rheumatoid Arthritis Disease

Pakistan Journal of Nutrition
NutritionDieteticsPublic HealthFood ScienceEnvironmentalOccupational Health
2012English

Golimumab: A Novel Anti-Tumor Necrosis Factor

Biologics in Therapy
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy